Samrat Pharmachem reports standalone net loss of Rs 0.40 crore in the March 2025 quarter

Sales decline 13.88% to Rs 71.20 crore

Net loss of Samrat Pharmachem reported to Rs 0.40 crore in the quarter ended March 2025 as against net profit of Rs 1.40 crore during the previous quarter ended March 2024. Sales declined 13.88% to Rs 71.20 crore in the quarter ended March 2025 as against Rs 82.68 crore during the previous quarter ended March 2024.

For the full year,net profit rose 229.17% to Rs 7.11 crore in the year ended March 2025 as against Rs 2.16 crore during the previous year ended March 2024. Sales rose 1.52% to Rs 285.86 crore in the year ended March 2025 as against Rs 281.58 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	71.20	82.68	-14	285.86	281.58	2
OPM %	0.18	1.66	-	3.58	0.88	-
PBDT	-0.20	1.56	PL	10.53	3.17	232
PBT	-0.36	1.40	PL	9.88	2.52	292
NP	-0.40	1.40	PL	7.11	2.16	229

Powered by Capital Market - Live News